Bio Medica Laboratories Ltd IPO
Pharmaceuticals
Price Band
₹132 – ₹139
Lot Size
1000
Minimum Bid Quantity
2000
Minimum Investment
₹278000
Issue Size
₹52.43Cr
Opens
2026-05-21
Closes
2026-05-25
Listing
29-05-2026
Subscription Status
Qualified Institutional Buyers
15.94 x
Non-Institutional Investor
1.27 x
Retail Individual Investor
2.92 x
Total
2.19 x
IPO Details
Issue Type
EQUITY
Face Value
₹10
Tick Size
1
ISIN
INE1BKA01015
Pre-Apply Available
No
Daily Bidding Time
10:00:00 - 17:00:00
About the Company
Bio Medica Laboratories Limited (BMLL) is a Madhya Pradesh-based company engaged in the manufacturing of pharmaceutical parenteral formulations. The company was incorporated in 2015 and converted into a public limited company in October 2024. BMLL manufactures generic drugs in the form of injectables, specifically liquid injections and dry powder injections, available in single-dose and multi-dose forms. These products cater to both human and veterinary needs. The company operates on a B2B contract manufacturing model, producing formulations for other companies as per their specific requirements, and does not sell directly to end users. The company operates from a single manufacturing facility in Madhya Pradesh. It holds Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP) certificates issued by the Food and Drugs Administration, Madhya Pradesh. Its in-house laboratory is equipped with instruments including HPLC, GC, and UV-Vis Spectrophotometer for testing and quality control purposes.
Pros
- • The company is led by promoters Mr. Pradeep Mehta and Mr. Mukesh Mehta, who collectively have over 37 years of experience in the pharmaceutical industry. This leadership has been instrumental in guiding the company's growth and operations since its incorporation.
- • BMLL manufactures 71 types of formulations, spanning generic drugs, branded pharmaceuticals, and over-the-counter (OTC) products. These are produced in both single-dose and multi-dose forms, catering to human and veterinary needs, allowing the company to serve multiple market segments through a single manufacturing setup.
- • The company holds GMP and GLP certificates issued by the Food and Drug Administration, Madhya Pradesh. It claims to maintain an in-house quality control team that conducts testing of both raw materials and finished goods throughout the manufacturing process.
Cons
- • The operations at the company's manufacturing unit-1 in Indore were suspended by the Deputy Director and State Licensing Authority, Food and Drug Administration, Madhya Pradesh, citing non-compliances under Rule 85(2) of the Drugs and Cosmetics Rules, 1945. As a result, the company is legally prohibited from carrying out production activities at this facility. If the licence is ultimately cancelled, the company would be required to undergo a time-consuming re-application process, further disrupting operations and impacting business performance. Following the suspension of manufacturing unit 1, the company is now reliant on manufacturing unit 2 to fulfil all customer demand. This concentration of production in a single operational facility increases the risk of supply disruption and may lead to increased operational costs, production schedule adjustments, and an inability to scale output in line with demand.
- • The top five customers contributed Rs 19.29 crore (67.58%), Rs 23.73 crore (62.13%), Rs 4.75 crore (31.15%), and Rs 5.58 crore (34.38%) to revenue from operations for FY25, FY24, and FY23, respectively. Any failure to retain these key customers or a loss of business from them can adversely affect the company's business and financial standing.
- • Both its manufacturing units are located in the Industrial Area, Sanwer Road, Indore, Madhya Pradesh. Any adverse political, social, economic, or regulatory developments in this region, including power supply disruptions, industrial disputes, or compliance-related directives from local authorities, could negatively impact the company's production and overall business operations.
Get real-time IPO alerts on WhatsApp
Opening reminders • Subscription updates • GMP alerts • Allotment results
Start WhatsApp Alerts